NIH-funded research R01 grant

How skin fat cells turn into scar-making cells

Official title: Defining the role of mechanoresponsive adipocyte-to-fibroblast transition in wound fibrosis.

Funded at Stanford University · NIH-11296877 · Data updated 2026-11-12

This project looks at how fat cells in skin change into scar-forming cells during wound healing to help people with scarring.

More Fibrosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startMay 1, 2023
Project endFebruary 29, 2028
Funding year2026
Award (this year)$325,107
NIH project number5R01AR081343-04
Project IDNIH-11296877 on NIH RePORTER

Who could benefit from this research

Could help

This project is preclinical and does not enroll patients now, but adults with new or problematic skin wounds or scars could be candidates for future related trials.

Less likely to help

People without skin wounds or those with non-skin fibrotic diseases are unlikely to receive direct benefit from this work.

What this research studies

Researchers will use genetic labeling and specialized mouse models to follow individual skin fat cells and see if they become fibroblasts that produce scar tissue. They will examine wounds using tissue stains, immunohistochemistry, and flow cytometry to define the molecular features of those lineage-derived cells. The team will perform single-cell molecular analyses and clonal tracing to map which cells expand and how they behave. They will also change the mechanical properties of wound tissue to test whether stiffness drives the fat-to-fibroblast conversion.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or reduce scarring and improve healing and function after skin injuries.

How similar studies have gone: Previous studies have reported fat-to-fibroblast transitions in wounds, but using that knowledge to prevent scarring remains largely untested.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Longaker, Michael T — Stanford University
  • Study coordinator: Longaker, Michael T

Related research

Other NIH-funded projects on the same topics.

  • Using the protein PIP to help heal corneal scarring

    This project uses a naturally occurring protein called PIP to try to reduce scarring and help the cornea heal in people with corneal injuries or disease.

    NIH research University of North Texas Hlth Sci Ctr · Fort Worth, United States · NIH-11285218

  • Investigating a protein's role in healing corneal wounds and preventing scarring

    This study is looking at a protein called Prolactin-Induced Protein (PIP) to see how it helps heal eye injuries and prevent scarring that can cause vision problems, with the hope of finding new treatments that could reduce the need for surgeries like corneal transplants.

    NIH research University of North Texas Hlth Sci Ctr · Fort Worth, United States · NIH-11049118

  • Understanding how fat cells change into scar-forming cells in healing wounds.

    This study is looking at how fat cells in your skin can change into scar-making cells when you heal from a wound, and it aims to find new ways to help reduce scarring for anyone who has had a cut or injury.

    NIH research Stanford University · Stanford, United States · NIH-11042278

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • How often to treat schistosomiasis to protect the liver

    A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.

    NIH research Rhode Island Hospital · Providence, United States · NIH-11607872

  • Metabolic changes in cells that repair blood vessels in the eye lens to prevent scarring

    A drug or approach that changes how certain cells that repair blood vessels in the eye work, to prevent scarring behind the retina in age-related macular degeneration patients treated with anti-VEGF therapy.

    NIH research University of Texas Hlth Sci Ctr Houston · Houston, United States · NIH-11603221

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.